GLYCOMET TRIO 2/0.3 TAB
Original price was: ₹201.15.₹181.03Current price is: ₹181.03.
Glycomet Trio 2/0.3 Tablet is a medicine that contains Glimepiride, Metformin, and Voglibose, used for managing type 2 diabetes mellitus.
Description
Glycomet Trio 2/0. 3 Tablet is a combination medication that contains Glimepiride, Metformin, and Voglibose as its active ingredients. Glimepiride belongs to the class of sulfonylureas and helps in controlling blood sugar levels by stimulating the release of insulin from the pancreas. Metformin is a biguanide medication that reduces glucose production in the liver and improves insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that slows down the digestion and absorption of carbohydrates, thus preventing a sudden surge in blood sugar levels after meals. This medicine is primarily prescribed for the management of type 2 diabetes mellitus. It helps control blood sugar levels by enhancing insulin production, reducing glucose production, and inhibiting post-meal hyperglycemia. Regular monitoring of blood sugar levels and periodic follow-ups are recommended to assess the effectiveness of treatment.
Additional information
| Marketed by | |
|---|---|
| Composition | |
| Dosage form | TABLET |
| Prescription | REQUIRED |
| Therapeutic use | ANTI DIABETICS |
